Skip to main content
Clinical Trials/NCT03220334
NCT03220334
Completed
Phase 3

Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection

Keimyung University Dongsan Medical Center1 site in 1 country20 target enrollmentJune 1, 2017

Overview

Phase
Phase 3
Intervention
Platelet rich plasma
Conditions
Platelet-rich Plasma
Sponsor
Keimyung University Dongsan Medical Center
Enrollment
20
Locations
1
Primary Endpoint
Recovery of artificial gastric ulcer
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

In Korea, where the prevalence of gastric tumors is high, the use of ESD as a treatment for gastric cancer will continue to increase. Considering that there are no special measures to prevent side effects (bleeding, perforation, etc.) of this procedure, it is possible to reduce the large medical costs through the discovery of substances that can promote gastric mucosal healing. Mechanism of PRP-based materials in the regeneration of gastric mucosal damage can be used to understand the pathophysiology of ulcers. In the future, it can be suggested as a new treatment for gastrointestinal tract damage such as intractable ulcer, perforation, mucosal fistula, gastrointestinal bleeding caused by esophagus, small intestine and large intestine as well as ulcer treatment by endoscopic procedure.

Detailed Description

Background:In Korea, where the prevalence of gastric tumors is high, the use of ESD as a treatment for gastric cancer will continue to increase. Considering that there are no special measures to prevent side effects (bleeding, perforation, etc.) of this procedure, it is possible to reduce the large medical costs through the discovery of substances that can promote gastric mucosal healing. Platelet-rich plasma (PRP) has demonstrated efficacy in preclinical endoscopic resection models. Aim: Evaluate the efficacy of PRP on participants submitted to ESD. Material and Methods: The investigators have evaluated a prospective clinical study. The investigators have included 10 participants submitted to ESD. Patients were informed and accepted to participate with a written consent. Prior to endoscopy PRP was obtained from autologous blood with a commercial kit. Resection was performed with standard technique. Immediately after the procedure, autologous PRP is applied to the artificial gastric ulcer using endoscopic spray. Participants were followed-up after the procedure.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
October 31, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

YooJin Lee

Assistant professor

Keimyung University Dongsan Medical Center

Eligibility Criteria

Inclusion Criteria

  • Endoscopic lesion submitted to endoscopic resection (ESD)

Exclusion Criteria

  • Ineligibility to endoscopic resection
  • Patients who declined to participate in this study
  • Patients who had hematologic diseases

Arms & Interventions

Apply platelet rich plasma to the artificial gastric ulcer

Intervention: Platelet rich plasma

Apply normal saline to the artificial gastric ulcer

Intervention: Normal saline

Outcomes

Primary Outcomes

Recovery of artificial gastric ulcer

Time Frame: 2 weeks

Measure the ulcer size with an endoscopy.

Secondary Outcomes

  • Recovery of artificial gastric ulcer(4 weeks)
  • Occurrence of postprocedure complication(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials